intimation of receipt of Order form the Hon''ble High Court of Telangana, Hyderabad by the promoters of the Company.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma's promoters received an adverse court order regarding a SEBI insider trading settlement case. The promoters—Mr. P.V. Ramprasad Reddy, Ms. P. Suneela Rani, Mr. Kambam Prasad Reddy, and Trident Chemphar Limited—had filed a writ petition to challenge SEBI's October 2020 directive to deposit Rs. 6.53 crores in profits (plus 12% interest) into the Investor Protection and Education Fund. This was in connection with alleged violations of insider trading regulations under SEBI PIT Regulations, 1992. The Hon'ble High Court of Telangana dismissed the writ petition on May 6, 2026. The promoters will decide on further legal action in consultation with their legal advisors. The company clarified that since the order is against the petitioners (promoters), there is no impact on Aurobindo Pharma's financials or operations.
The company itself faces no financial or operational impact as the order is directed at the promoters. However, this creates reputational concerns around promoter-level insider trading allegations and ongoing regulatory scrutiny that may worry some investors.